ロード中...
The Methyl-CpG-Binding Protein Mbd2 Regulates Susceptibility to Experimental Colitis via Control of CD11c(+) Cells and Colonic Epithelium
Methyl-CpG-binding domain-2 (Mbd2) acts as an epigenetic regulator of gene expression, by linking DNA methylation to repressive chromatin structure. Although Mbd2 is widely expressed in gastrointestinal immune cells and is implicated in regulating intestinal cancer, anti-helminth responses and colon...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7033935/ https://ncbi.nlm.nih.gov/pubmed/32117307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00183 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|